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FD-2 Pre-flight press briefing 
Example of cephalad fluid shift 
Inflight: Fluid shift 
• Central venous pressure? 
• Stroke volume – cardiac output? 
• Blood pressure 
Cardiac preload: 
Cardiac afterload: 
• Systemic vascular resistance 
Cardiac muscle mass 
• Blood volume? 
• Baroreflexes – sympathetic nervous ac. 
 
 
Central venous pressure in space 
 
CVP  Seated Supine,legs-up 0 G 
(cm H2O, N = 3) 
_______________________________________ 
 
     8.4         15.0  2.5 
_______________________________________ 
 
       Buckey et al., 
       J. Appl. Physiol. 
       81:19-25, 1996. 
 

G 
Foldager et al. J. Appl. Physiol. 
81: 408-12, 1996 


Videbæk & Norsk , J. Appl. Physiol. 
83: 1862-66, 1997 
1 G 
Heart distension in 0 G 
0
Mechanism? 
The pressure in the inter- 
pleural space surrounding the 
heart is decreased by 0 G. 
Therefore: 
This pressure must also be 
measured! 
Mechanism? 
Cardiac distension 
pressure 
Mechanism? 
Atrial distension 
pressure 
Mechanism? 
Atrial distension 
pressure 
= 
CVP ! 
Leach et al., 1991 
TBW results differ between 
studies, however all spaceflight 
studies are low “n” studies.  
Regardless of mechanism, it is 
known that PV is decreased. 
Plasma volume losses are similar after  
short and long-duration spaceflight 
Meck JV, et al. Marked Exacerbation of Orthostatic Intolerance after Long- vs. Short-Duration  
Spaceflight in Veteran Astronauts. Psychosomatic Medicine 63:865-873, 2001. 
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Where does the plasma volume go? 
Figures from Leach et al. 1996 in Watenpaugh DE. Fluid volume control during short-term space flight and implications for huma  
J Exp Biology 204 (18):3209-3215, 2001. 
Prisk et al. 
J. Appl. Physiol. 
75:15-26,1993. 
Cardiac output 
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Heart rate 
Systolic 
Diastolic 
Pre- In- Postflight 
Fritsch-Yelle et al. 
J. Appl. Physiol. 
80:919-914, 1996. 
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Compared to the supine 
position? 
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Figure 1. Baroreflex testing The left panel shows astronaut Rhea Seddon performing 
baroreflex testing on herself during the SLS-1 mission. 
Eckberg D L et al. J Physiol 2010;588:1129-1138 
©2010 by The Physiological Society 
Figure 3. Mean ± 95% confidence intervals for preflight and inflight vagal baroreflex relations 
Confidence limits for carotid distending pressures are obscured by the symbols. 
Eckberg D L et al. J Physiol 2010;588:1129-1138 
©2010 by The Physiological Society 
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Norsk et al. 
J. Appl. Physiol. 
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Ertl A C et al. J Physiol 2002;538:321-329 
©2002 by The Physiological Society 
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Norsk et al. 
J. Appl. Physiol. 
78: 2253-59, 1995 
Research Evidence for Decreased LV 
Mass 
during Exposure to Microgravity 
Perhonen MA, Franco F, Lane LD, et al. Cardiac atrophy after bed rest and spaceflight. J Appl Physiol 91: 645-653, 20
Cardiac MRI was conducted pre-flight and post-flight: 10 days of microgravity exposure 
It is unclear on what post-flight day MRI data was acquired and there was no follow-up   
Postflight: 
• Orthostatic tolerance 
• Aerobic exercise capacity 
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Presyncope increases with Flight Duration 
83% 20%
80% 25%
Women Men 
presyncopal non-presyncopal 
Isotonic Fluid Load 
 
The operational fluid load 
(salt tablets and water before 
landing) was imposed to 
correct the dehydration. Used 
static stand test and 
cardiovascular index of 
deconditioning (CID) to 
quantify results. 
 
However, the efficacy of the 
operational fluid load was not 
determined: it is unknown 
how much plasma volume is 
actually replaced. 
 
Does not restore plasma 
volume to pre-flight levels: 
currently, there is 
approximately a 9% loss 
Bungo MW, Charles JB, Johnson PC. Cardiovascular Deconditioning During Space 
Flight and the Use of Saline as a Countermeasure to Orthostatic Intolerance. Aviat. 
     
Orthostatic intolerance: 
•    Oral salt and fluid loading 
 
•     Antigravity garment 
 
•     Additional clinical treatment 
Mitigated by: 
 
Florinef® Does not Correct Post-spaceflight Orthostatic 
Hypotension 
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Catecholamine Responses to Standing 
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    †p = 0.058  *p ≤ 0.05 **p ≤ 0.01 
presyncopal women (n=4) 
presyncopal men (n=6) 
non-presyncopal men (n=22) 
Preflight Landing Day Three Days  
Postflight 
Maximum Oxygen Uptake Preflight, 
In-flight and Postflight (all max tests) 
Levine et al., Maximal exercise performance after adaptation to microgravity. 
JAP 81(2): 686-694, 1996. 
However - 
Sympathetic nervous activity 
is high in space! 
Vasodilatation 
and 
sympathetic 
activation 
     
     how? 
Hypothesis: 
Norsk & Christensen 
Respir .Physiol. Neurobiol. 
169 (Suppl. 1):S26-9, 2009. 
Paoli Nespoli 
European Space Agency astronaut 
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